Startups
2009
BIONURE FARMA SL Promoting Neuroprotection: First-in-class SGK agonists for rare ophthalmological conditions
Company integrated with Iproteos to form Accure Therapeutics
Company integrated with Iproteos to form Accure Therapeutics
Address
Carrer de Sant Joan de Malta 145, 08018 Barcelona, Spain
Finance Data
CERCA ownership
Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Bionure is a clinical stage company developing first-in-class SGK agonists for the treatment of rare ophthalmological diseases for which no treatment options are nowadays available. We focus in particular in two conditions in which patients suffer from significant vision impairment: acute optic neuritis and neuromyelitis optica.
With these patients in mind, we have built an extraordinary committed team of experts in neuro-ophthalmology and neuro-inflammation, passionate about bringing meaningful therapies to society with the aim of changing the life of thousands of people.
With these patients in mind, we have built an extraordinary committed team of experts in neuro-ophthalmology and neuro-inflammation, passionate about bringing meaningful therapies to society with the aim of changing the life of thousands of people.
Product description
Our lead candidate BN201 has been granted orphan designation for optic neuritis in Europe and the United States and has shown compelling evidence of neuroprotective and remyelinating activity in several animal models. Bionure is currently undertaking a Phase 1 clinical trial of the compound BN201 in the United Kindom.
Promoting Neuroprotection: First-in-class SGK agonists for rare ophthalmological conditions
Addressing Optic Neuritis, Neuromyelitis Optica and Multiple Sclerosis by promoting neuroprotection and remyelination
Promoting Neuroprotection: First-in-class SGK agonists for rare ophthalmological conditions
Addressing Optic Neuritis, Neuromyelitis Optica and Multiple Sclerosis by promoting neuroprotection and remyelination